Tamoxifen and endometrial cancer: new data for an old problem. Review.
Tamoxifen, a nonsteroidal antiestrogen, is used for pre- and postmenopausal patients with breast cancer. Data on a possible association of endometrial pathologies with Tamoxifen treatment have been accumulating. The current literature and our experience are presented.
Leo
L
L
Department B of the Gynecology and Obstetrics Institute, University of Torino, Italy.
Tessarolo
M
M
Febo
G
G
Farina
C
C
Nuzzo
L
L
Arduino
S
S
Wierdis
T
T
Lanza
A
A
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use*
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen